Form 4 for TGEN TECOGEN INC.
Accepted 2025-06-24 00:00:00 ET · period of report 2025-03-03 · accession 0001537435-25-000064 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-24 | 2025-03-03 | TGEN | Lafaille Stephen | VP of Business Development | P - Purchase | $2.50 | +400 | 400 | New | +$1,000 |
| DM | 2025-06-24 | 2025-06-03+ | TGEN | Lafaille Stephen | VP of Business Development | X - OptEx | $0.9375 | +60.0K | 10.4K | New | +$56.2K |
| DM | 2025-06-24 | 2025-06-03+ | TGEN | Lafaille Stephen | VP of Business Development | S - Sale+OE | $5.76 | -60.0K | 400 | -99% | -$345.8K |
| DM | 2025-06-24 | 2025-06-03+ | TGEN | Lafaille Stephen | VP of Business Development | X - OptEx | $0.9375 | -60.0K | 40.0K | -60% | -$56.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | P | A | 400 | $2.50 | 400 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-03 | X | A | 10,000 | $0.71 | 10,400 | D | — | — | (F1) Shares acquired pursuant to exercise of Stock Option Agreement dated 7/9/2020 |
| 3 | Common | Common Stock | 2025-06-03 | S | D | 10,000 | $4.88 | 400 | D | — | — | (F2) Multiple share sales between $4.75 and $5.25 per share |
| 4 | Common | Common Stock | 2025-06-04 | X | A | 15,000 | $0.71 | 15,400 | D | — | — | (F1) Shares acquired pursuant to exercise of Stock Option Agreement dated 7/9/2020 |
| 5 | Common | Common Stock | 2025-06-23 | S | D | 10,000 | $7.25 | 400 | D | — | — | |
| 6 | Common | Common Stock | 2025-06-06 | X | A | 25,000 | $1.10 | 25,400 | D | — | — | (F4) Shares acquired pursuant to stock option agreement dated 1/21/2022 |
| 7 | Common | Common Stock | 2025-06-06 | S | D | 25,000 | $5.98 | 400 | D | — | — | (F5) Multiple share sales between $5.85 and $6.10 |
| 8 | Common | Common Stock | 2025-06-23 | X | A | 10,000 | $1.10 | 10,400 | D | — | — | (F4) Shares acquired pursuant to stock option agreement dated 1/21/2022 |
| 9 | Common | Common Stock | 2025-06-04 | S | D | 15,000 | $5.00 | 400 | D | — | — | (F3) 10,000 shares sold for $4.90 per share, and 5,000 shares sold for $5.10 per share |
| 10 | Derivative | Stock Options (Right to Buy) | 2025-06-06 | X | D | 25,000 | $1.10 | 27,500 | D | $1.10 · 2023-01-21 to 2032-01-21 | 52,500 Common Stock | (F7) Vests 50% per year |
| 11 | Derivative | Stock Options (Right to Buy) | 2025-06-23 | X | D | 10,000 | $1.10 | 17,500 | D | $1.10 · 2023-01-21 to 2032-01-21 | 25,000 Common Stock | (F7) Vests 50% per year |
| 12 | Derivative | Stock Options (Right to Buy) | 2025-06-04 | X | D | 15,000 | $0.71 | 25,000 | D | $0.71 · — to 2030-07-09 | 40,000 Common Stock | (F6) Vests 50% upon achievement of Adjusted EBITDA goal of 2% of revenue in two consecutive quarters, and 50% upon achievement of Adjusted EBITDA goal of 3% of revenue in four consecutive quarters |
| 13 | Derivative | Stock Options (Right to Buy) | 2025-06-03 | X | D | 10,000 | $0.71 | 40,000 | D | $0.71 · — to 2030-07-09 | 50,000 Common Stock | (F6) Vests 50% upon achievement of Adjusted EBITDA goal of 2% of revenue in two consecutive quarters, and 50% upon achievement of Adjusted EBITDA goal of 3% of revenue in four consecutive quarters |